FKBP52 Polyklonaler Antikörper

• Featured Product
• KD/KO Validated

FKBP52 Polyklonal Antikörper für WB, IHC, IF/ICC, IP, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte und mehr (1)

Anwendung

WB, IHC, IF/ICC, IP, ELISA

Konjugation

Unkonjugiert

Publikationen

17

Kat-Nr. : 10655-1-AP

Synonyme

FKBP4, FKBP-4, FK506-binding protein 4, EC:5.2.1.8, 52 kDa FK506-binding protein

---

Galerie der Validierungsdaten

• 

  WB analysis using 10655-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 10655-1-AP (FKBP52 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 10655-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 10655-1-AP (FKBP52 antibody) at dilution of 1:8000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of PC-3 using 10655-1-AP

  PC-3 cells were subjected to SDS PAGE followed by western blot with 10655-1-AP (FKBP52 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of PC-3 using 10655-1-AP

  PC-3 cells were subjected to SDS PAGE followed by western blot with 10655-1-AP (FKBP52 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of PC-3 using 10655-1-AP

  PC-3 cells were subjected to SDS PAGE followed by western blot with 10655-1-AP (FKBP52 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of Jurkat using 10655-1-AP

  Jurkat cells were subjected to SDS PAGE followed by western blot with 10655-1-AP (FKBP52 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of NIH/3T3 using 10655-1-AP

  NIH/3T3 cells were subjected to SDS PAGE followed by western blot with 10655-1-AP (FKBP52 antibody) at dilution of 1:300 incubated at room temperature for 1.5 hours.

• 

  IP experiment of HeLa using 10655-1-AP

  IP result of anti-FKBP52 (IP:10655-1-AP, 4ug; Detection:10655-1-AP 1:20000) with HeLa cells lysate 1360 ug.

• 

  IHC staining of human prostate cancer using 10655-1-AP

  Immunohistochemical analysis of paraffin-embedded human prostate cancer using 10655-1-AP (FKBP52 antibody) at dilution of 1:100 (under 25x lens).

• 

  IF Staining of MCF-7 using 10655-1-AP

  Immunofluorescent analysis of (-20°C Methanol) fixed MCF-7 cells using FKBP52 antibody (10655-1-AP) at dilution of 1:200 and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L).

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: HeLa-Zellen, C6-Zellen, Jurkat-Zellen, MCF-7-Zellen, NIH/3T3-Zellen, PC-3-Zellen, Rattenhodengewebe
• Erfolgreiche IP: HeLa-Zellen
• Erfolgreiche Detektion in IHC: humanes Prostatakarzinomgewebe; Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.
• Erfolgreiche Detektion in IF/ICC: MCF-7-Zellen

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:1000-1:8000
• Immunpräzipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
• Immunhistochemie (IHC): IHC : 1:20-1:200
• Immunfluoreszenz (IF)/ICC: IF/ICC : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• KD/KO: See 5 publications below
• WB: See 14 publications below
• IHC: See 4 publications below
• IP: See 1 publications below

Produktinformation

10655-1-AP bindet in WB, IHC, IF/ICC, IP, ELISA FKBP52 und zeigt Reaktivität mit human, Maus, Ratten

• Getestete Reaktivität: human, Maus, Ratte
• In Publikationen genannte Reaktivität: human, Huhn, Maus, Ratte
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: FKBP52 fusion protein Ag1019
• Vollständiger Name: FK506 binding protein 4, 59kDa
• Berechnetes Molekulargewicht: 52 kDa
• Beobachtetes Molekulargewicht: 52 kDa
• GenBank-Zugangsnummer: BC007924
• Gene symbol: FKBP52
• Gene ID (NCBI): 2288
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

FKBP52 (FK506 binding protein 4) is a member of the immunophilin protein family that comprises intracellular protein effectors of immunosuppressive drugs, and it is known as a steroid receptor-associated protein. As a novel regulator of microtubule dynamics, FKBP52 is associated with the motor protein dynein and with the cytoskeleton during mitosis. FKBP52 is highly expressed in CNS regions susceptible to Alzheimer's, and plays a role in modulating toxicity of Abeta peptides. The protein can associate with the Tau function, and may help to decipher and modulate the events involved in Tau-induced neurodegeneration. In addition, FKBP52 is likely to play a role in growth and development of the male genitalia.

Publikationen

Species	Application	Title
human	WB	Theranostics; FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer.; Authors - Alain Mangé ; KD Validated
human	WB,IHC	Clin Cancer Res; Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.; Authors - Desmetz Caroline C
human	WB，IP	Mol Oncol; FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells.; Authors - Keisuke Maeda ; KD Validated
human	WB	Int J Mol Sci; Secretome Analyses Identify FKBP4 as a GBA1-Associated Protein in CSF and iPS Cells from Parkinson's Disease Patients with GBA1 Mutations; Authors - Rika Kojima
human	WB	J Cell Physiol; Multiple roles for peptidylglycine α-amidating monooxygenase in the response to hypoxia.; Authors - Vishwanatha K S Rao
mouse	WB	RNA; The co-chaperones Fkbp4/5 control Argonaute2 expression and facilitate RISC assembly.; Authors - Martinez Natalia J NJ ; KD Validated